Bio Insurance
(Cell Banking)

cells have the ability to differentiate into various cells, regenerate, and produce new cells that may replace damaged or aged ones.

Over the past 50 years, CHA Group’s excellent research infrastructure and unsurpassed expertise in bio research have made it possible to cure previously incurable diseases that otherwise cannot be treated by traditional surgical or medicinal therapies. For example, CHA Hospital in Los Angeles has succeeded in clinical testing for a breast reconstruction procedure in which fat grafting is enhanced by stem cells. The CHA Hospital in LA also provided stem cell therapy for a knee ligament injury for a famous athlete in the United States by preserving his stem cells.

CHA has also seen success in cord blood transplantation for a child with cerebral palsy. This groundbreaking treatment has brought us one step closer to one day curing Stargardt's disease, an ophthalmologic condition caused by a genetic mutation known as macular degeneration, which is a primary cause of blindness and Parkinson's disease, a major brain-nervous system disease.

In the past 50 years, CHA Medical Group has developed the world’s top technical skills for cell research and led the way in cell and tissue cryopreservation technology with notable achievements in the field of bio research. CHA Medical Group recently opened the CHA Bio Complex, in which all of our research and expertise and efforts in bio research are concentrated with the goal of emerging as the world’s best bio medical group.

A modern day Mecca for stem cell research, CHA Medical Group is internationally recognized as the world’s leading stem cell institute. CHA offers one-stop service and covers everything from blood collection and storage to treatment that utilizes our internationally acclaimed cell storage techniques.